1. (1) A pharmacist shall provide the patient or patient’s agent consultation to optimize proper use of a prescription drug or device, that meets any of the following:

   1. (a) Has not been dispensed previously to the patient.
   2. (b) Is a change in therapy.
   3. (c) Upon request of a patient or patient’s agent.
   4. (d) Whenever deemed necessary based upon the professional judgement of the dispensing pharmacist.

2. (2) Notwithstanding sub. (1), consultation is not required when one of the following occurs:

   1. (a) A drug or device will be administered, by ingestion, inhalation, injection, or any other route, by or in the presence of one of the following:

      1. 1. An individual with a scope of practice that includes the administration of a drug or device.
      2. 2. A delegate of an individual with authority to delegate the administration of a drug or device.
   2. (b) A patient or patient’s agent refuses consultation.

3. (3) Consultation shall contain any of the following information that, in the pharmacist’s professional judgment, serves the best interest of the patient:

   1. (a) Name and description of the drug.
   2. (b) Form, dose, route of administration and duration for drug therapy.
   3. (c) Intended use of the drug and expected action.
   4. (d) Directions and precautions for the preparation, administration, and use.
   5. (e) Common severe side or adverse effects or interactions and therapeutic contraindications that may be encountered, including their avoidance, and the action required if they occur.
   6. (f) Techniques for self-monitoring drug therapy.
   7. (g) Action to be taken in the event of a missed dose.
   8. (h) Proper storage and appropriate disposal method of unwanted or unused medication.
4. (4) The consultation required in this section shall be communicated verbally when in the pharmacist’s professional judgment it is in the best interest of the patient.
5. (5) A pharmacist shall provide the patient or patient’s agent, for all consultations required under sub. (1), a written patient drug education monograph.
6. (6) The consultation required in this section may occur before or after delivery of the prescription to the patient or patient’s agent.
7. (7) Every licensed pharmacy dispensing directly to a patient or patient’s agent inside the pharmacy shall conspicuously post a board approved sign stating a patient’s rights to pharmacist consultation and information on how to file a complaint to the board.
8. (8) A prescription drug or device delivered by common carrier, mail, or delivery service or picked up at a drive through window shall include a copy of information which is board-approved stating a patient’s rights to pharmacist consultation and information on how to file a complaint to the board.

History

History: CR 19-145: cr. Register December 2020 No. 780, eff. 1-1-21; correction in (3) (d) made under s. 35.17, Stats., Register December 2020 No. 780.